illumina

Illumina is a global leader in DNA sequencing and array technologies, founded in 1998 and headquartered in San Diego, California, with the mission of advancing human health by unlocking the power of the genome. Its core business spans high- to low-throughput sequencing instruments, consumables (accounting for over 70% of revenue), software and bioinformatics platforms (e.g., DRAGEN), and multi-omics solutions. In 2025, Illumina launched BioInsight, an AI-driven unit to accelerate drug discovery, while continuing to upgrade its NovaSeq X platform—targeting Q70 data quality, a 40% increase in output, and 30% faster run times. The company also introduced the TruPath Genome whole-genome sequencing solution and DRAGEN v4.5 analysis software. In the fourth quarter of 2025, Core Illumina revenue grew 5% year over year (constant currency), driven by strong consumables performance, especially in clinical sequencing.

Products: